The earnings call presented a strong financial performance with record revenue growth and increased operating income. The successful launch of new products and a strengthening balance sheet were key highlights. However, noncash expenses affecting earnings per share and the competitive market for key products posed challenges.

Company Guidance -

Q1 2026

During the Elite Pharmaceuticals Conference Call for the fiscal year ending March 31, 2025, significant financial metrics were discussed. The company's total revenues reached $84 million, marking a 52% increase from the previous year's $56.6 million. This growth was largely attributed to the launch of the Elite label and the introduction of the Lisdexamfetamine product line, which captured a substantial market share despite intense competition. Operating income rose to $19.6 million, an 82% increase from the prior year. However, a noncash expense of $18.9 million, due to a change in the fair value of derivatives, led to a pretax loss of $52,000. Despite this, the company reported a positive operating cash flow of $7.5 million, a significant turnaround from a $3.2 million cash burn in the previous year. The balance sheet showed a robust increase in working capital to $45.9 million, up 41% from the prior year, with current assets rising and liabilities decreasing, underscoring Elite's improved financial health.

Record Revenue Growth

Total revenues for the fiscal year 2025 were $84 million, representing a 52% increase over the previous year.

Significant Increase in Operating Income

Operating income was $19.6 million, an increase of 82% compared to the previous fiscal year.

Successful Launch of Lisdexamfetamine

Launched in the last quarter of the fiscal year, the Lisdexamfetamine product line contributed significantly to revenue growth amidst a competitive market.

Strong Market Share in Key Products

Elite commands a market share of approximately 8-10% for Lisdexamfetamine, 20% for Adderall IR, and 16% for Adderall XR.

Improved Cash Flow

Operating cash flow was positive at $7.5 million, a $10.7 million improvement from a cash burn of $3.2 million in the previous year.

Strengthening Balance Sheet

Working capital increased by 41% to $45.9 million, with a decrease in current liabilities and low debt levels.

Elite Pharmaceuticals (ELTP) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ELTP Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 18, 2025	2026 (Q1)	- / -	0.001	―	―	―
Jun 30, 2025	2025 (Q4)	- / 0.02	0.001	1500.00% (+0.01)	―
Feb 13, 2025	2025 (Q3)	- / -0.01	0.001	-1100.00% (-0.01)	―
Nov 14, 2024	2025 (Q2)	- / -0.01	0.015	-166.67% (-0.03)	―
Aug 14, 2024	2025 (Q1)	- / -	0.001	―	―
Jul 01, 2024	2024 (Q4)	- / <0.01	0.001	0.00% (0.00)	―
Feb 14, 2024	2024 (Q3)	- / <0.01	0.003	-66.67% (>-0.01)	―
Nov 14, 2023	2024 (Q2)	- / 0.01	0.002	650.00% (+0.01)	―
Aug 14, 2023	2024 (Q1)	- / <0.01	0	―	―
Jun 29, 2023	2023 (Q4)	- / >-0.01	0.002	-200.00% (>-0.01)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ELTP Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jun 30, 2025	$0.73	$0.67	-8.22%
Feb 13, 2025	$0.55	$0.53	-3.64%
Nov 14, 2024	$0.52	$0.56	+7.69%
Aug 14, 2024	$0.20	$0.19	-5.00%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Elite Pharmaceuticals (ELTP) report earnings?

Elite Pharmaceuticals (ELTP) is schdueled to report earning on Aug 18, 2025, TBA (Confirmed).

What is Elite Pharmaceuticals (ELTP) earnings time?

Elite Pharmaceuticals (ELTP) earnings time is at Aug 18, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ELTP EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing